Investor Pullout From India Pharma’s Research Feared A Signal For More (India)
This article was originally published in PharmAsia News
Executive Summary
Some analysts fear decisions by investors to pull out of Perlecan Pharma's drug-research effort will lead to more pullouts in India. They said that could hurt drug research initiatives in India because they would find funding sources more difficult to obtain. Sources said two investor groups are discussing cancelling involvement with Perlecan, Dr. Reddy's research arm, because they are concerned about the efficacy of the molecules it was researching. One analyst noted such a pullout has not happened before in India's pharmaceutical business and other major drug makers also have separated their research units. (Click here for more